Therefore, blocking CD40-CD40L interactions could provide a means to treat autoimmune diseases involving CD8+ T cell-mediated epithelial cell hyperplasia and fibrosis in the thyroid as well as other tissues or organs [16,39,41,42]. This evidence concerns the gene CD40 and autoimmune disease.